GeneSystem Co

GeneSystem Co Enterprise Value

The Enterprise Value (EV) of GeneSystem Co (363250.KQ) as of Oct 29, 2026 is 35.50 B KRW. In the previous year, Enterprise Value (EV) was 29.05 B KRW — a change of 22.20% (higher).

Enterprise Value

35.50 BKRW

YoY

22.20%

Last updated:

Enterprise Value (EV) of GeneSystem Co is 2025 35.50 B KRW. Enterprise Value (EV) of GeneSystem Co was 2024 29.05 B KRW. It decreases by 22.20% higher compared to the previous year.

The GeneSystem Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
33.89 B KRW
Jan 1, 2019
35.10 B KRW
Jan 1, 2020
28.36 B KRW
Jan 1, 2021
-104.74 M KRW
Jan 1, 2022
11.01 B KRW
Jan 1, 2023
20.11 B KRW
Jan 1, 2024
29.05 B KRW
Jan 1, 2025
35.50 B KRW
The GeneSystem Co Enterprise Value history
YEAREnterprise ValueYoY
35.50 BKRW+22.20%
29.05 BKRW+44.44%
20.11 BKRW+82.77%
11.01 BKRW-10,607.29%
-104.74 MKRW-100.37%
28.36 BKRW-19.20%
35.10 BKRW+3.56%
33.89 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneSystem Co Stock analysis

What does GeneSystem Co do? GeneSystem Co., Ltd generates revenue through the development, manufacturing, and sale of PCR-based molecular diagnostic products. The company offers molecular diagnosis systems, biochips, test kits, and reaction reagents, targeting healthcare providers and laboratories seeking advanced in vitro diagnostic solutions. Its core business focuses on molecular diagnosis technology, complementing immunodiagnosis technology to deliver comprehensive diagnostic tools. The firm serves medical institutions requiring precise and efficient diagnostic equipment for disease detection and monitoring. The company's product portfolio includes platform-based molecular diagnostic systems, biochips, and test kits designed for laboratory use. These products are sold directly to healthcare facilities and diagnostic laboratories, supporting applications in infectious disease testing and genetic analysis. By leveraging its expertise in molecular diagnosis, GeneSystem Co., Ltd provides essential tools for medical professionals to enhance diagnostic accuracy and patient care. GeneSystem Co., Ltd's revenue streams are derived from the sale of diagnostic systems, biochips, and consumables such as test kits and reaction reagents. The firm's target market comprises healthcare institutions and laboratories that require reliable in vitro diagnostic technology. The company's focus on molecular diagnosis technology positions it as a key supplier in the diagnostic equipment sector, meeting the growing demand for advanced diagnostic solutions in healthcare. GeneSystem Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneSystem Co stock

Enterprise Value (EV) of GeneSystem Co is 35.50 B KRW in 2025.

Enterprise Value (EV) of GeneSystem Co changed from 29.05 B KRW to 35.50 B KRW, representing a 22.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) GeneSystem Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s KRW, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' KRW varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s GeneSystem Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — GeneSystem Co

All Key Metrics — GeneSystem Co